Form 4 · Filed Jun 10, 2026, 09:22 PM UTC
ONC/BeOne Medicines Ltd.
OYLER JOHN — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | S | sell | 3,820 | $270 | $1,032,870 | 1,120 |
| Jun 8, 2026 | S | sell | 1,120 | $271 | $303,678 | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001042047-26-000004